Skip to content
Tirzepatide Report
Provider review

TeleClinic Tirzepatide Review: Intro Plans & Refund Stages

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Selected monthly and three-month tirzepatide introductions with membership price-lock wording.

Standout details

  • Actual public one- and three-month selections publish their full initial amounts
  • Selected 5 mg and 30 mg vial strengths retain the advertised plan prices

Things to consider

  • Introductory price and lifetime-membership wording require the accepted enrollment terms; no separate renewal amount is established
  • Medication nonapproval protection does not erase a separate state-required consultation fee after review

TeleClinic’s named compounded-tirzepatide page labels $149 for a one-month introductory option and $399 total for the first three months. It also describes introductory pricing locked for the life of a membership. Obtain the selected term, vial strength and applicable price-lock agreement; neither an old review amount nor a lower equivalent should replace the current written quote.3,4

Compare the full selected term

The public menu lists vial strengths from 5 mg to 30 mg per 2 mL vial and says the provider selects appropriate dosing. The advertised one- and three-month amounts remain unchanged with either the 5 mg or 30 mg vial choice selected. A vial’s total content is different from a weekly prescribed dose. Ask for the number of vials, supplied period, first amount collected and next renewal, without using the menu to select a clinical regimen.3

The Telezen MD review separates a quarterly charge from a monthly option and explains why neither label identifies the prescribed supply. Compare the full payment term and medication quantity together.

The FormBlends review provides a useful first-payment versus refill comparison: $149 for its introductory month, then $239 for a monthly purchase or $214 on optional Subscribe & Save renewals. Compare the continuing charge and renewal authorization separately; TeleClinic’s membership price-lock wording should be checked against its own accepted enrollment terms.8

The product says consultation, medication, shipping and ongoing support are included, with the same price at every dose. Its Terms nevertheless allow a separate consultation fee where permitted by state law. Confirm whether that exception applies to the selected plan instead of treating an inclusion headline as a promise that no other service can cost anything.3,4

TeleClinic: introductory plan labels

Published detailDecision before payment
One-month introductory option: $149Confirm the selected vial strength and recurring bill.
First three months: $399 totalDo not read the total as a monthly payment.
Vial-strength menu: 5–30 mg per 2 mLThese are vial labels, not weekly-dose recommendations.
Price-lock wording for membershipGet the applicable enrollment terms and conditions.
The named page labels both options introductory and separately describes price-lock conditions.3,4

Nonapproval and ordinary cancellation are separate

The Terms say subscriptions renew automatically unless canceled before renewal. Cancellation through the portal or support takes effect at the end of the current billing period, without routine prorated refunds for partial periods. Obtain the next billing date and written confirmation that future renewal has stopped.4

The Refund Policy says a person who does not qualify is not charged for medication; if a charge was processed before that decision, it is refunded within five business days. It separately makes a state-required consultation fee nonrefundable after a physician reviews the intake, regardless of prescribing outcome. Preserve that distinction when asking what a declined request actually costs.5

The policy lists exceptions to ordinary no-proration, including cancellation within 24 hours of initial enrollment when no medication has been dispensed, physician-initiated medical discontinuation and a qualifying company billing or technical error. These are stage-specific exceptions, not an unrestricted trial or routine return of used medication.5

The TeleCareSpot review examines a different cutoff: its FAQ excludes refunds after the pharmacy processes an order. Compare that processing event with an exception tied to medication not yet dispensed, and confirm which fees the accepted agreement covers.

TeleClinic: refund stages differ

Published detailDecision before payment
Clinician declines treatmentMedication not charged; processed medication charge refunded.
Separate state-required consultation feeNonrefundable after review, regardless of prescription.
Initial 24 hours and no medication dispensedPolicy lists an exception to ordinary no-proration.
Damaged or incorrect shipmentReport with photos within 48 hours; see policy conditions.
A medication nonapproval exception does not erase a separately applicable consultation fee.4,5

Delivery remedies have their own deadlines

For damaged, compromised or incorrect shipments, the policy asks for contact and photos within 48 hours of receipt, describing replacement or refund choices under its conditions. Confirmed lost packages have a separate replacement window before a refund. A compounding or dispensing error may result in a corrected shipment or refund at the company’s discretion.5

A broader request section uses 14 days from delivery or expected delivery for non-delivery, with approved refunds processed in five to ten business days. Do not use that general window to ignore a shorter shipment-reporting deadline, or confuse company processing with a guaranteed bank-credit date.5

Rush Pharmacy is a named disclosure

The product and pharmacy-partner page name Rush Pharmacy. This supports a named pharmacy relationship, while the site’s descriptions of 503A status, accreditation and current licensure remain attributed claims rather than independently checked credentials. Ask which facility will dispense the actual prescription and confirm the label and location eligibility.3,6

Teleclinic Holdings LLC describes a technology platform connecting patients with independent clinicians rather than practicing medicine itself. The existence of a public price or intake questionnaire does not guarantee treatment, a particular strength or suitability of a compounded preparation.4

Clinical evidence and individual care

Compounded tirzepatide is not an FDA-approved finished drug.7 SURMOUNT-1 and SURMOUNT-5 studied specific products and treatment protocols; they do not establish this service’s outcomes or equivalence of a compounded preparation, microdose regimen or oral formulation.1,2 Confirm the actual prescription, risks, alternatives and label instructions with the treating clinician.

Further reading

whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · TeleCareSpot · Ondra Health · TeleZen MD · best tirzepatide providers

Frequently asked questions

Is TeleClinic’s three-month offer a $399 monthly charge?

No. The named page labels $399 as the total for the first three months, alongside a $149 one-month introductory option. Confirm the actual selected term, vial strength, next bill and price-lock conditions.

If TeleClinic does not prescribe, is every fee refunded?

The policy says no medication charge applies when treatment is declined, or a processed medication charge is refunded. A separate state-required consultation fee may remain nonrefundable once a physician reviews the intake.

Does TeleClinic identify a pharmacy?

Its product and pharmacy-partner page name Rush Pharmacy. The site’s pharmacy credential assertions are not independent verification of current licenses, accreditation or a particular patient’s prescription.

References(8)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. TeleClinic (2026). Compounded Tirzepatide: introductory terms, vial strengths and inclusions. TeleClinic.
  4. TeleClinic (2026). Terms of Service: subscriptions, cancellation and clinical nonapproval. TeleClinic.
  5. TeleClinic (2026). Refund Policy: exceptions, request windows and consultation fees. TeleClinic.
  6. TeleClinic (2026). Pharmacy Partners: Rush Pharmacy disclosure. TeleClinic.
  7. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. Read source
  8. FormBlends (2026). Pricing: introductory month, upfront plans and subscriber renewals. FormBlends.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.